TrialLeukemia2021
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE.
Hartmut Goldschmidt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it